EE9900118A - H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel - Google Patents

H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel

Info

Publication number
EE9900118A
EE9900118A EEP199900118A EE9900118A EE9900118A EE 9900118 A EE9900118 A EE 9900118A EE P199900118 A EEP199900118 A EE P199900118A EE 9900118 A EE9900118 A EE 9900118A EE 9900118 A EE9900118 A EE 9900118A
Authority
EE
Estonia
Prior art keywords
treatment
nasal polyps
atpase inhibitors
atpase
inhibitors
Prior art date
Application number
EEP199900118A
Other languages
English (en)
Other versions
EE04043B1 (et
Inventor
Lennart Lindberg Per
Pinas-Masso Joan
Serra-Carreras Jordi
Trofast Jan
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900118A publication Critical patent/EE9900118A/et
Publication of EE04043B1 publication Critical patent/EE04043B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
EEP199900118A 1996-10-11 1997-10-01 H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks EE04043B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment
PCT/SE1997/001651 WO1998016228A1 (en) 1996-10-11 1997-10-01 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS

Publications (2)

Publication Number Publication Date
EE9900118A true EE9900118A (et) 1999-10-15
EE04043B1 EE04043B1 (et) 2003-06-16

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900118A EE04043B1 (et) 1996-10-11 1997-10-01 H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks

Country Status (34)

Country Link
EP (1) EP0946175B1 (et)
JP (1) JP4100713B2 (et)
KR (1) KR100510812B1 (et)
CN (1) CN1146416C (et)
AR (1) AR008886A1 (et)
AT (1) ATE230597T1 (et)
AU (1) AU738310B2 (et)
BR (1) BR9711896A (et)
CA (1) CA2268305C (et)
CZ (1) CZ298799B6 (et)
DE (1) DE69718347T2 (et)
DK (1) DK0946175T3 (et)
EE (1) EE04043B1 (et)
ES (1) ES2188995T3 (et)
HK (1) HK1022848A1 (et)
HU (1) HUP0000036A3 (et)
ID (1) ID23692A (et)
IL (1) IL129324A0 (et)
IS (1) IS1930B (et)
MY (1) MY117918A (et)
NO (1) NO321007B1 (et)
NZ (1) NZ334786A (et)
PL (1) PL190902B1 (et)
PT (1) PT946175E (et)
RS (1) RS49599B (et)
RU (1) RU2197966C2 (et)
SA (1) SA97180641B1 (et)
SE (1) SE9603725D0 (et)
SK (1) SK284252B6 (et)
TR (1) TR199900770T2 (et)
TW (1) TW568784B (et)
UA (1) UA59374C2 (et)
WO (1) WO1998016228A1 (et)
ZA (1) ZA978842B (et)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
US6270747B1 (en) 1998-08-18 2001-08-07 The University Of California In vitro and in vivo assay for agents which treat mucus hypersecretion
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
EP1453493A2 (en) * 2001-11-19 2004-09-08 ALTANA Pharma AG Reversible proton pump inhibitors for the treatment of airway disorders
US20050131026A1 (en) * 2002-03-14 2005-06-16 Atlanta Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders
AU2003227710A1 (en) * 2002-05-07 2003-11-11 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
JP2005526848A (ja) * 2002-05-07 2005-09-08 アルタナ　ファルマ　アクチエンゲゼルシャフト 気道疾患を治療するための組み合わせ
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
WO2004052374A1 (en) 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005025578A1 (en) 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
HUP0000036A2 (hu) 2002-05-29
DK0946175T3 (da) 2003-03-17
PT946175E (pt) 2003-04-30
MY117918A (en) 2004-08-30
CA2268305C (en) 2006-11-28
SE9603725D0 (sv) 1996-10-11
EP0946175A1 (en) 1999-10-06
DE69718347T2 (de) 2003-08-28
CZ298799B6 (cs) 2008-02-06
DE69718347D1 (de) 2003-02-13
AU4640997A (en) 1998-05-11
BR9711896A (pt) 1999-08-24
HU0000036D0 (et) 2002-05-29
RU2197966C2 (ru) 2003-02-10
CN1146416C (zh) 2004-04-21
JP4100713B2 (ja) 2008-06-11
HK1022848A1 (en) 2000-08-25
IL129324A0 (en) 2000-02-17
KR20000049046A (ko) 2000-07-25
IS1930B (is) 2004-05-18
SK284252B6 (sk) 2004-12-01
CZ122999A3 (cs) 1999-09-15
WO1998016228A1 (en) 1998-04-23
ID23692A (id) 2000-05-11
NO991619D0 (no) 1999-04-06
CN1232397A (zh) 1999-10-20
CA2268305A1 (en) 1998-04-23
PL332692A1 (en) 1999-09-27
ATE230597T1 (de) 2003-01-15
TR199900770T2 (xx) 1999-06-21
AU738310B2 (en) 2001-09-13
SA97180641B1 (ar) 2005-12-18
RS49599B (sr) 2007-06-04
JP2001508034A (ja) 2001-06-19
SK38499A3 (en) 2000-03-13
PL190902B1 (pl) 2006-02-28
IS5021A (is) 1999-04-08
AR008886A1 (es) 2000-02-23
ES2188995T3 (es) 2003-07-01
EP0946175B1 (en) 2003-01-08
KR100510812B1 (ko) 2005-08-31
YU16399A (sh) 2000-03-21
NO991619L (no) 1999-04-06
HUP0000036A3 (en) 2003-02-28
NZ334786A (en) 2000-12-22
EE04043B1 (et) 2003-06-16
UA59374C2 (uk) 2003-09-15
NO321007B1 (no) 2006-02-27
ZA978842B (en) 1998-04-14
TW568784B (en) 2004-01-01

Similar Documents

Publication Publication Date Title
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
DK1304992T3 (da) Topisk gel-fremföringssystem til behandling af hudlidelser
DE69929047D1 (de) Haarbehandlungsmittel
FI20000863A (fi) Uusi hoitomenetelmä
DE60001421T2 (de) Behandlung von abgas
EE200100370A (et) Teraapias kasutatavad spirofuropüridiinide uued aralküülamiinid
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
IS6560A (is) Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni
EE9900118A (et) H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel
IS5756A (is) Notkun hreinljósvirks (+) -norkisapríðs við meðhöndlun á öndunarstöðvun, lotugræðgi og öðrum meinum
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
NO20013337L (no) Ny behandling
NO20013596D0 (no) Slambehandling
DE60037935D1 (de) Kontinuierliches behandlungssystem
DE60023003D1 (de) Haarbehandlungsmittel
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
DK1135128T3 (da) Nye behandlingsfremgangsmåder
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
SI0946175T1 (en) USE OF A COMBINATION OF H+, K+ -ATPase INHIBITORS AND GLUCOCORTICOIDS IN THE TREATMENT OF NASAL POLYPS
FI20002612A0 (fi) Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi
NO985325D0 (no) Anvendelse av substituert azaspiran ved behandling av astma
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
SE9903421D0 (sv) Behandlingsförfarande

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20081001